CoreAge Rx vs Shapely
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Shapely head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 63 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Shapely a bad call — it's best for eligible patients in california, florida, new york or texas who want provider and dietitian visits and can budget separately for medication. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Shapely |
|---|---|---|
| Brief Score | 94/100 (A) | 63/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Medication + required care membership Monthly drug: $139 low-mid dose/$179 high dose. Three-month starter/refill $297; high-dose $477. Self-pay membership $99/month, $49 first month, extra. Labs excluded from care fee, typically insurance-covered or $75 as advertised. Full selected treatment, patient cancellation and package-refund calculation unconfirmed. Full price detailsCompounded semaglutide offered; complete selected-plan total unknown; three-month starter/refill package $297 or high-dose $477 plus required membership; monthly medication $139 low-mid dose or $179 high dose |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Medication + required care membership Monthly drug: $249 low-mid dose/$299 high dose. Three-month starter $498, refill $597, high-dose $837, plus required membership. Self-pay care $99/month, $49 first month; medication costs extra. Eligibility listed for CA, FL, NY and TX. Confirm package supply and refund terms. Full price detailsCompounded tirzepatide offered; complete selected-plan total unknown; three-month starter $498, refill $597 or high-dose $837 plus required membership; monthly medication $249 low-mid dose or $299 high dose |
| Coverage | US only; restrictions by state, confirmed at intake | California, Florida, New York and Texas for adults18+ under current medication-page eligibility FAQ; verify insurance and treatment eligibility |
| Brand-name access | Not confirmed | Current catalog advertises oral Wegovy, Foundayo and named injectable brands; medication coverage and costs are separate from membership and require prescription/insurance review. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Shapely: Self-pay care is $99 monthly, $49 first month, plus medication. Three-month drug totals vary by dose and plan. Four-state eligibility applies; obtain the patient cancellation and refund agreement.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.